PharmaceuticalsDrug Recall: Q&A with Beth Riggio Last updated: May 9, 2024 4:43 pm By bexib 0 Min Read Share SHARE Beth Riggio, Vice President of Product Management, Global Products and Solutions at Cencora, discusses the challenges the industry faces with recalls and how to improve them.You Might Also Like AstraZeneca’s $80 billion sales target by 2030 reflects industry trend toward long-term bets Filling the data gap Biotech’s path to recovery heads for uncertainty Sapiens Launches AI-Powered Insurance Platform Gilead aims to ‘end the HIV epidemic’ through incremental progress Share This Article Facebook X Email Print Previous Article How AI improves keyword research Next Article What’s happening at Belgian ports should worry American automakers and policymakers Leave a CommentLeave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment *Name * Email * Website Save my name, email, and website in this browser for the next time I comment. Stay ConnectedFacebookLikeXFollowYoutubeSubscribeTelegramFollowLatest News Five payment trends in Asia that will shape the financial landscape in 2025 Fintech BNPL drives growth for suppliers and retailers Retail & E-commerce Hotel chef obtains new qualification Hospitality & Tourism Print the shirt with 3D James Nobak Manufacturing SearchSearchRecent PostsFive payment trends in Asia that will shape the financial landscape in 2025BNPL drives growth for suppliers and retailersHotel chef obtains new qualificationPrint the shirt with 3D James NobakIHG Hotels & Resorts Announces Public Space Design of Innovative Experience Holiday Inn ExpressRecent Comments